Literature DB >> 18260297

[Retinal ganglion cells death in glaucoma--mechanism and potential treatment. Part II].

Wojciech Rokicki1, Mariola Dorecka, Wanda Romaniuk.   

Abstract

Glaucoma is a kind of optic neuropathy where selective retinal ganglion cell loss is the major hallmark. Frequently glaucoma is associated with elevated intraocular pressure, but this condition is neither necessary nor sufficient for onset and progression of the disease. The exact mechanism(s) of ganglion cell death in glaucoma and fully effective treatment of glaucomatous neuropathy still remain unknown. This article reviews the recent researches relevant to IOP-independent risk factors, mechanisms of RGC death and modern potential therapeutic strategies in glaucoma. Part two includes review of ionic derangements, reactive oxygen species cytotoxicity, role of nitric oxide and immunity disorder findings in glaucoma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18260297

Source DB:  PubMed          Journal:  Klin Oczna        ISSN: 0023-2157


  6 in total

1.  Secondary neuroprotective effects of hypotensive drugs and potential mechanisms of action.

Authors:  Grace C Shih; David J Calkins
Journal:  Expert Rev Ophthalmol       Date:  2012-04

2.  Laser refractive surgery in glaucoma patients.

Authors:  Essam Osman
Journal:  Saudi J Ophthalmol       Date:  2010-04-21

3.  Partial Optic Nerve Transection in Rats: A Model Established with a New Operative Approach to Assess Secondary Degeneration of Retinal Ganglion Cells.

Authors:  Fancheng Yan; Sailiang Guo; Yijie Chai; Lan Zhang; Kegao Liu; Qingjun Lu; Ningli Wang; Shuning Li
Journal:  J Vis Exp       Date:  2017-10-15       Impact factor: 1.355

4.  Retinal Ganglion Cell Diversity and Subtype Specification from Human Pluripotent Stem Cells.

Authors:  Kirstin B Langer; Sarah K Ohlemacher; M Joseph Phillips; Clarisse M Fligor; Peng Jiang; David M Gamm; Jason S Meyer
Journal:  Stem Cell Reports       Date:  2018-03-22       Impact factor: 7.765

5.  Differential susceptibility of retinal ganglion cell subtypes in acute and chronic models of injury and disease.

Authors:  Kirstin B VanderWall; Bin Lu; Jorge S Alfaro; Anna R Allsop; Alexa S Carr; Shaomei Wang; Jason S Meyer
Journal:  Sci Rep       Date:  2020-10-15       Impact factor: 4.379

6.  Mindfulness Meditation Can Benefit Glaucoma Patients.

Authors:  Tanuj Dada; Meghal Gagrani
Journal:  J Curr Glaucoma Pract       Date:  2019 Jan-Apr
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.